Stay updated with breaking news from Cordella Sensor. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
/PRNewswire/ -- Endotronix, Inc., a digital health and medical technology company dedicated to advancing the treatment of heart failure (HF), today announced...
Endotronix announced today that it submitted a premarket approval (PMA) application to the FDA for its Cordella system.
/PRNewswire/ -- Endotronix, Inc., a digital health and medical technology company dedicated to advancing the treatment of heart failure (HF), announced it has...
The PROACTIVE-HF 2 trial is designed to expand access to NYHA class II patients and to scale pulmonary artery pressure-guided therapy with the Cordella Sensor
University Hospital Galway (UHG) has completed the final phase of an innovative clinical trial which reduces the hospitalisation rate for patients living with heart failure.